Marketwire
CARLSBAD, CALIFORNIA--(Marketwired - Oct. 2, 2013) - Aurora Spine Corporation (TSX VENTURE:ASG) announced today it will be exhibiting its product portfolio in Liverpool, UK at EuroSpine 2013 in booth H51 (Hall 2), from October 2nd until October 4th. This is the company's first time showcasing at the annual EuroSpine tradeshow.
The company then will participate at the North American Spine Society ("NASS") tradeshow taking place in New Orleans, LA, USA, October 9th through October 12th. You can visit Aurora Spine at booth 1141.
At this year's meetings, Aurora Spine will present products including the ZIP™ MIS Interspinous Fusion System and Aurora Biologics, giving attendees a glimpse into the Aurora portfolio.
About Aurora Spine
Aurora Spine is an early stage company focused on bringing new solutions to the spinal implant market through a series of innovative, minimally invasive, regenerative spinal implant technologies.
Forward-Looking Statements
This news release contains forward-looking information that involves substantial known and unknown risks and uncertainties, most of which are beyond the control of Aurora Spine, including, without limitation, those listed under "Risk Factors" and "Cautionary Statement Regarding Forward-Looking Information" in Aurora Spine's final prospectus (collectively, "forward-looking information"). Forward-looking information in this news release includes information concerning the growth potential of Aurora Spine's products. Aurora Spine cautions investors of Aurora Spine's securities about important factors that could cause Aurora Spine's actual results to differ materially from those projected in any forward-looking statements included in this news release. Any statements that express, or involve discussions as to, expectations, beliefs, plans, objectives, assumptions or future events or performance are not historical facts and may be forward-looking and may involve estimates, assumptions and uncertainties which could cause actual results or outcomes to differ unilaterally from those expressed in such forward-looking statements. No assurance can be given that the expectations set out herein will prove to be correct and, accordingly, prospective investors should not place undue reliance on these forward looking statements. These statements speak only as of the date of this press release and Aurora Spine does not assume any obligation to update or revise them to reflect new events or circumstances.